Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
34.08
-1.73 (-4.83%)
Sep 9, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Employees
Alto Neuroscience had 68 employees as of December 31, 2025. The number of employees decreased by 8 or -10.53% compared to the previous year.
Employees
68
Change (1Y)
-8
Growth (1Y)
-10.53%
Revenue / Employee
n/a
Profits / Employee
-$1,238,794
Market Cap
1.34B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | -8 | -10.53% |
| Dec 31, 2024 | 76 | 9 | 13.43% |
| Sep 30, 2024 | 88 | 27 | 44.26% |
| Jun 30, 2024 | 78 | 17 | 27.87% |
| Mar 31, 2024 | 67 | - | - |
| Sep 30, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 465 |
| MeiraGTx Holdings | 393 |
| Alumis | 239 |
| Omeros | 175 |
| Maze Therapeutics | 141 |
| Alpha Tau Medical | 121 |
| ORIC Pharmaceuticals | 111 |
| Cullinan Therapeutics | 109 |
ANRO News
- 8 hours ago - Alto Neuroscience Announces Participation in Upcoming Investor Conferences - Business Wire
- 12 days ago - Alto Neuroscience names Nick Smith president, CFO - TheFly
- 13 days ago - Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer - Business Wire
- 23 days ago - Alto Neuroscience price target raised to $55 from $50 at H.C. Wainwright - TheFly
- 23 days ago - Alto Neuroscience reports Q EPS (65c), consensus (77c) - TheFly
- 23 days ago - Alto Neuroscience price target raised to $37 from $28 at BTIG - TheFly
- 24 days ago - Alto Neuroscience price target raised to $37 from $33 at BofA - TheFly
- 4 weeks ago - Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights - Business Wire